|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/167 | (2006.01) |
| A61K 31/325 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2872482 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13817231.7 |
| Date of filing the European patent application | 2013-03-07 | |
| (97) | Date of publication of the European application | 2015-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation | 2020-12-28 |
| (86) | Number | PCT/US2013/029667 |
| Date | 2013-03-07 |
| (87) | Number | WO 2014/011220 |
| Date | 2014-01-16 |
| (30) | Number | Date | Country code |
| 201261671366 P | 2012-07-13 | US | |
| 201261726274 P | 2012-11-14 | US |
| (72) |
DALTON, James, T., US
STEINER, Mitchell, S., US
NARAYANAN, Ramesh, US
AHN, Sunjoo, US
|
| (73) |
Oncternal Therapeutics, Inc.,
3525 Del Mar Heights Road Suite 821, San Diego, CA 92130-2122,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Krūties vėžių gydymo būdas selektyviu androgeno receptoriaus moduliatoriumi |
| A METHOD OF TREATING BREAST CANCERS WITH SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 13 | 289.00 EUR |
| 2026-03-07 |